Endocrinologist
BLOG: Musings on birthdays and retirement
ENDO canceled due to COVID-19 concerns
As diabetes technologies advance, matching patients to the ‘right’ device challenges providers
Diabetes devices such as sensors, insulin pumps and continuous glucose monitors continue to improve, offering people with diabetes more opportunities for connected care. As a result, adoption of these technologies is gradually rising. Approximately 30% to 40% of people with type 1 diabetes and an increasing number of people with insulin-dependent type 2 diabetes are using pump and sensor technology, according to a 2018 review published in Diabetes Care. Another recent study shows CGM can be cost-effective for adults with diabetes when compared with the daily use of test strips and improves overall blood glucose levels while reducing hypoglycemia.
VIDEO: FH can be vehicle for precision public health
ATLANTA — In this video exclusive, Daniel J. Rader, MD, chair of the department of genetics, chief of the division of translational medicine and human genetics, the Seymour-Gray Professor of Molecular Medicine at the University of Pennsylvania Perelman School of Medicine and chief science adviser for the FH Foundation, spoke with Katherine Wilemon, founder and CEO of the FH Foundation, about major takeaways from the FH Foundation’s FH Global Summit, which focused on familial hypercholesterolemia as a driver for precision public health.